Found 11 matching trials
Reprab Study: PLD + Trabectedin Rechallenge PHASE2 RECHALLENGE WITH PEGYLATED LIPOSOMAL DOXORUBICIN ADDED TO TRABECTEDIN IN RE...
Show More Location
Fondazione Policlinico Gemelli IRCCS
Learn More & Join Trial
Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC N/A Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and P...
Show More Location
Multiple Locations
Learn More & Join Trial
An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer N/A Clinical trials are, due to the inclusion and exclusion criteria, accomplis...
Show More Location
Praxis und Tagesklinik für gynäkologische Onkologie
Learn More & Join Trial
Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer PHASE3 This is an open-label, prospective, randomized, controlled, parallel group,...
Show More Location
Klinikum Aschaffenburg-Alzenau
Learn More & Join Trial
Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum N/A Observational, clinical study. Intention to include 40 patients (20 patient...
Show More Location
Multiple Locations
Learn More & Join Trial
Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients N/A Non-interventional, multicenter, prospective, European study to describe th...
Show More Learn More & Join Trial
QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer PHASE4 This is a multicenter, randomized, controlled, open-label study including p...
Show More Location
Universitätsklinikum Aachen
Learn More & Join Trial
Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer PHASE2 Effect of biweekly schedule of PLD on dose-limiting toxicity of PPE and pat...
Show More Location
Multiple Locations
Learn More & Join Trial
Retrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLD N/A The median age at which ovarian cancer is diagnosed is 63 years (50-75). Th...
Show More Location
Hospital Universitario Reina Sofía
Learn More & Join Trial
An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer N/A This is a Non-interventional, Multicenter study evaluating the efficacy and...
Show More Location
Almaty oncological center
Learn More & Join Trial